MAPK1 and cancer: The survival-inhibiting and pro-apoptotic effects of miR-34a in combination with the anti-cancer agents, prompted us to study the modulation of two key molecules involved in the regulation of both cell proliferation and survival, MAPK (ERK-1 and ERK-2) and AKT.